!

URGENT: SB 432, which will enable Big Pharma to raise drug costs even higher, just moved one step closer to passing. 

Washington Post: CVS agrees to buy Aetna in $69 billion deal that could shake up health-care industry

December 13, 2017

Pharmacy giant CVS Health has agreed to buy Aetna in a $69 billion blockbuster acquisition that could rein in health-care costs and transform its 9,700 pharmacy storefronts into community medical hubs for primary care and basic procedures, the companies announced Sunday afternoon.

CVS.jpg

The pharmacy chain agreed to buy Aetna for about $207 per share, broken down into $145 in cash and the rest in stock. The deal — the biggest health-care merger announced in more than a year — is expected to close in the second half of 2018, subject to approval by shareholders and regulators.

If approved, the megamerger would create a giant consumer health-care company with a familiar presence in thousands of communities. Aetna chief executive Mark T. Bertolini described the vision in an interview as “creating a new front door for health care in America.”

Read more on this from The Washington Post.

 


View Comments on This Article (1)   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Bundled Payments May Save Money in Healthcare
Podcast: Representative Wants Opportunities for New Healthcare Plans
Blue Cross and Blue Shield North Carolina to Cut Some Rates, Raise Others

Featured Articles

Tell your representative to say "no" to higher drug costs
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income
Pharma Company Increases Drug Price by 909% as Wholesale Rates Soar
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC